Learn more
Log in
0 followers
InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a.
Industries
Headquarters
Stage
Employees
Links
Niels C. Riedemann
4 members
3 members
2 members
Calico
7 followers
TeOra Lifescience Pte Ltd
1 follower
Kriya Therapeutics
Genentech
128 followers
Thermo Fisher Scientific
110 followers
Discover companies